Nothing Special   »   [go: up one dir, main page]

Gaspar-Rodríguez et al., 2021 - Google Patents

Coronavirus persistence in human respiratory tract and cell culture: An overview

Gaspar-Rodríguez et al., 2021

View HTML @Full View
Document ID
3014014061185740534
Author
Gaspar-Rodríguez A
Padilla-González A
Rivera-Toledo E
Publication year
Publication venue
Brazilian Journal of Infectious Diseases

External Links

Snippet

Emerging human coronaviruses, including the recently identified SARS-CoV-2, are relevant respiratory pathogens due to their potential to cause epidemics with high case fatality rates, although endemic coronaviruses are also important for immunocompromised patients. Long …
Continue reading at www.scielo.br (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—AIDS or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/576—Immunoassay; Biospecific binding assay for hepatitis

Similar Documents

Publication Publication Date Title
Ochani et al. COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management
Gaspar-Rodríguez et al. Coronavirus persistence in human respiratory tract and cell culture: An overview
De Gascun et al. Human polyomavirus reactivation: disease pathogenesis and treatment approaches
Li et al. Production of infectious dromedary camel hepatitis E virus by a reverse genetic system: Potential for zoonotic infection
Munoz et al. Emerging viral infections and their impact on the global burden of neurological disease
Gosert et al. CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytes
Park et al. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
Johansson Respiratory syncytial virus infection: an innate perspective
Arellano-Galindo et al. Detection and gB genotyping of CMV in Mexican preterm infants in the context of maternal seropositivity
Fragkou et al. Update in viral infections in the intensive care unit
Grudlewska-Buda et al. SARS-CoV-2—morphology, transmission and diagnosis during pandemic, review with element of meta-analysis
Khan et al. Diagnostic approaches and potential therapeutic options for coronavirus disease 2019
Williams et al. A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system
Aziz et al. COVID-19 impacts, diagnosis and possible therapeutic techniques: a comprehensive review
Fiorino et al. SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses
Mutso et al. Basic insights into Zika virus infection of neuroglial and brain endothelial cells
Mansourabadi et al. Serological and Molecular Tests for COVID-19: a recent update
Le Marechal et al. COVID-19 in clinical practice: A narrative synthesis
Reno et al. Parvovirus B19: A Clinical and Diagnostic Review
Zeidler et al. What do we know about SARS-CoV-2 virus and COVID-19 disease?
Gogoi et al. Suspected SARS-Cov-2 reinfections in health care workers from Assam, India: Are they true reinfections
Johnston et al. Human herpesviruses: herpes simplex virus types 1 and 2
Esneau et al. Rhinovirus diversity and virulence factors
Saha et al. Antibody response to SARS-CoV-2 in HIV patients co-infected with COVID-19
Omilabu et al. Medically important airborne viruses